Mathew Stephens
Sales & Marketing at Endomagnetics Ltd.
Profile
Mathew Stephens is currently working as the Commercial Director at Endomagnetics Ltd.
He started this position in 2016.
Prior to his current role, he worked as the Principal at S.R.A.
Developments Ltd.
Mathew completed his undergraduate degree at the University of Bath.
Mathew Stephens active positions
| Companies | Position | Start |
|---|---|---|
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Sales & Marketing | 2013-07-31 |
Former positions of Mathew Stephens
| Companies | Position | End |
|---|---|---|
S.R.A. Developments Ltd.
 S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Corporate Officer/Principal | - |
Training of Mathew Stephens
| University of Bath | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
S.R.A. Developments Ltd.
S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Mathew Stephens
